Münevver Demir

17PUBLICATIONS
62CO-AUTHORS
Medical infection agents (incl. prions)PharmacogenomicsToxicology (incl. clinical toxicology)Socio-economic developmentCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Oct 05, 2026
Microbiota-host genetic interactions modulate MASLD risk in PNPLA3I148M carriers via ceramides and are reversible by targeted microbial interventions.

|Sep 22, 2026
A consensus-based guideline for personalized bacteriophage therapy.

|Jul 09, 2026
Non-absorbable antibiotics worsen alcohol-associated liver disease in gastric acid-suppressed mice.

|Jun 13, 2026
Socioeconomic Factors and Their Role in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Comprehensive Review.

|May 27, 2026
Recent Advances in the Diagnosis and Management of Clinically Significant Portal Hypertension in Liver Cirrhosis: A Clinical Review.

|Jan 02, 2026
Bile salt hydrolase activity as a rational target for MASLD therapy.

Elizabeth V Jones, Yongtao Wang, Wenchao Wei

Pageof 3

Frequent Collaborators

4 joint publications

Frank Tacke

3 joint publications

Sonja Lang

3 joint publications

Bernd Schnabl

3 joint publications

Philipp Kasper